|

Brexpiprazole Clinical Trials

4 actively recruiting trials

Also known as: Rexulti

Pipeline

Phase 3: 1Phase 4: 1

Top Sponsors

  • The University of Hong Kong1
  • Nova Scotia Health Authority1
  • Dr. Albert Kar-Kin Chung1
  • Douglas Mental Health University Institute1

Indications

  • Depression4
  • Schizophrenia and Related Disorders1
  • Bipolar Depression1
  • Psychosis1
  • Major Depressive Disorder1

Other4 trials

Brexpiprazole Treatment for Bipolar I Depression
Phase 3
Optimized Predictive Treatment In Medications for Unipolar Major Depression (OPTIMUM-D)
Phase 4
Real-life Assessment of Abilify Maintena + Rexult in Schizophrenia
Real-life Assessment of Brexpiprazole (Rexulti) in Schizophrenia and in Depressive Disorders

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.